Selzentry Patient Population Needs Further Definition, Advisory Panel Urges

Determining the effect of Pfizer's Selzentry (maraviroc) in subpopulations of HIV patients was the theme of recommendations by the Antiviral Drugs Advisory Committee for post-marketing studies Oct. 8

Pink Sheet Podcast

Learn what's happening at the US FDA. On the go.

Derrick Gingery and the team bring you a weekly "Drug Fix".

More from Archive

More from Pink Sheet